Lipsky P E
J Clin Invest. 1984 Jan;73(1):53-65. doi: 10.1172/JCI111207.
It has been suggested that D-penicillamine is active in rheumatoid arthritis because of its capacity to function as a selective inhibitor of T lymphocyte function. The basis for the immunosuppressive action of this drug as well as mechanisms whereby the effect of D-penicillamine could be modified by elements of rheumatoid synovial tissue were examined. As previously reported, D-penicillamine, in the presence of copper ions markedly inhibited mitogen-induced human T lymphocyte DNA synthesis. Since the vast majority of copper in the body exists as an integral part of the ceruloplasmin molecule, the capacity of this cuproprotein to augment D-penicillamine-mediated inhibition of T cell function was examined. The requirement for copper ions could be entirely replaced by purified ceruloplasmin, which had been depleted of nonspecifically bound copper by passage over Chelex-100 columns. The mechanism by which D-penicillamine in the presence of either copper ions or ceruloplasmin caused inhibition of T lymphocyte responsiveness was examined. Partial protection from this inhibitory effect was accomplished by sodium borohydride. While superoxide dismutase had no protective effect, catalase was found to protect lymphocyte responsiveness totally from the inhibitory action of D-penicillamine and either copper ions or ceruloplasmin. Similarly, horseradish peroxidase and myeloperoxidase also protected responsiveness from these inhibitors while boiled catalase was without effect. These results indicate that inhibition of T lymphocyte responsiveness resulted from the generation of hydrogen peroxide. Since a number of cells likely to be present at chronic inflammatory sites, such as mononuclear phagocytes, contain enzymatic mechanisms to degrade hydrogen peroxide, the modulatory influence of these cells on the inhibition of T cell function caused by D-penicillamine and copper was examined. Monocytes, whose function was not suppressed by D-penicillamine and copper, were found to protect T lymphocyte responsiveness from the inhibitory effects of either the mixture of D-penicillamine and CuSO4 or of hydrogen peroxide. By contrast, endothelial cells, fibroblasts, or cells obtained from enzyme-digested noninflamed synovium could not protect T cells from the inhibitory effects of D-penicillamine and copper. Protection of T cells was afforded by means of a heat labile, azide-sensitive soluble factor present in lysates of human monocytes. These results indicate that the mechanism whereby D-penicillamine in the presence of copper or ceruloplasmin inhibits T lymphocyte responsiveness involves the generation of hydrogen peroxide and that other neighboring cells likely to be found w
有人提出,D-青霉胺在类风湿性关节炎中具有活性,是因为它能够作为T淋巴细胞功能的选择性抑制剂发挥作用。研究了这种药物免疫抑制作用的基础以及类风湿性滑膜组织成分改变D-青霉胺作用的机制。如先前报道,在铜离子存在的情况下,D-青霉胺显著抑制有丝分裂原诱导的人T淋巴细胞DNA合成。由于体内绝大多数铜以铜蓝蛋白分子的组成部分存在,因此研究了这种铜蛋白增强D-青霉胺介导的T细胞功能抑制的能力。铜离子的需求可以完全被纯化的铜蓝蛋白替代,该铜蓝蛋白通过Chelex-100柱去除了非特异性结合的铜。研究了在铜离子或铜蓝蛋白存在的情况下D-青霉胺导致T淋巴细胞反应性抑制的机制。硼氢化钠可部分保护免受这种抑制作用。虽然超氧化物歧化酶没有保护作用,但发现过氧化氢酶可完全保护淋巴细胞反应性免受D-青霉胺以及铜离子或铜蓝蛋白的抑制作用。同样,辣根过氧化物酶和髓过氧化物酶也能保护反应性免受这些抑制剂的影响,而煮沸的过氧化氢酶则没有效果。这些结果表明,T淋巴细胞反应性的抑制是由过氧化氢的产生引起的。由于许多可能存在于慢性炎症部位的细胞,如单核吞噬细胞,含有降解过氧化氢的酶机制,因此研究了这些细胞对D-青霉胺和铜引起的T细胞功能抑制的调节作用。发现单核细胞的功能不受D-青霉胺和铜的抑制,它们能保护T淋巴细胞反应性免受D-青霉胺和硫酸铜混合物或过氧化氢的抑制作用。相比之下,内皮细胞、成纤维细胞或从酶消化的非炎症滑膜中获得的细胞不能保护T细胞免受D-青霉胺和铜的抑制作用。人单核细胞裂解物中存在的一种对热不稳定、对叠氮化物敏感的可溶性因子可保护T细胞。这些结果表明,在铜或铜蓝蛋白存在的情况下D-青霉胺抑制T淋巴细胞反应性的机制涉及过氧化氢的产生,并且可能在其他邻近细胞中发现……